atscherter

atscherter

  • Joined: March 21, 2017
  • Articles: 3

First results of the QUESTIONNAIRE STUDY for DMD

People with Duchenne muscular dystrophy (DMD) often lack suitable educational opportunities and leisure activities. We conducted a survey to find out what impact Covid-19 has had on school attendance and leisure activities for children and young people with DMD. 40…

Article about Zolgensma® in Switzerland

Spinal muscular atrophy (SMA) is a severe neurodegenerative disease. For a few years now, SMA can be treated with genetic therapies. These new therapies include the gene therapy Zolgensma®. Zolgensma® has been approved in Switzerland for the treatment of children…